RESHAPE LIFESCIENCES INC (RSLS)
US76090R2004 - Common Stock
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GLXZ, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape and Vyome, a Clinical Stage Specialty Pharmaceutical Company Working To Treat Immuno-Inflammatory Diseases of Unmet Need, to Combine in All-Stock...
Why Is Cue Health (HLTH) Stock Down 40% Today?
Cue Health stock is down on Wednesday as HLTH investors react to the healthcare company filing for Chapter 7 bankruptcy relief.
Why Is Faraday Future (FFIE) Stock Down 32% Today?
Faraday Future stock is falling hard on Wednesday as FFIE investors aren't impressed by the company's earnings report for 2023.
Why Is Banzai International (BNZI) Stock Up 25% Today?
Banzai International stock is up Wednesday with heavy trading of BNZI shares after closing out a recent public offering.
Why Is Reshape Lifesciences (RSLS) Stock Up 80% Today?
Reshape Lifesciences stock is up on Wednesday with heavy trading of RSLS shares despite a lack of news from the company this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning!
RSLS Stock Earnings: Reshape Lifesciences Beats EPS, Misses Revenue for Q1 2024
RSLS stock results show that Reshape Lifesciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
RSLS Stock Earnings: Reshape Lifesciences Beats EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reshape Lifesciences (NASDAQ:RSLS) just reported results for the first quarter ...
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024...
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Wednesday, May 15, 2024
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Wednesday, May 15, 2024...
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023;...
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Patent Significantly Strengthens Intellectual Property Portfolio
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Patent Significantly Strengthens Intellectual Property Portfolio...
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for...